Second Sight
12744 San Fernando Road
Building 3
Sylmar
California
91342
United States
Tel: 818-833-5000
Fax: 818-833-5067
Website: http://www.2-sight.com/
110 articles about Second Sight
-
Nano Precision Medical Co-Founder and CEO Discusses Proposed Second Sight Merger in Interview to Air on Bloomberg U.S. on the RedChip Money Report®
4/14/2022
Second Sight Medical Products, Inc. today announced that an interview with Adam Mendelsohn, Ph.D. will air on The RedChip Money Report® on Bloomberg US on April 16 at 7 p.m. Eastern Time (ET).
-
Second Sight Medical Products Announces Proposed Public Offering of Common Stock
6/22/2021
Second Sight Medical Products, Inc. today announced that it intends to offer to sell shares of its common stock in an underwritten public offering.
-
Second Sight Medical Products Announces Year Three NIH Funding of Its Orion Study
5/13/2021
Second Sight Medical Products, Inc., a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announced that the Company received notice from the National Institutes of Health of the release of year three funding for its Early Feasibility Clinical Trial of a Visual Cortical Prosthesis, grant UH3NS103442.
-
Second Sight Medical Products Names Dean Baker and Alexandra Larson to its Board of Directors
4/6/2021
Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced that the Company’s Board of Directors has appointed two new members, Dr. Dean Baker and Ms. Alexandra Larson. Dr. Baker has also been appointed to the Audit Committee
-
Second Sight Medical Products Names Scott Dunbar Acting CEO
4/1/2021
Second Sight Medical Products, Inc., a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announced that the Company’s Board of Directors has named Scott Dunbar to replace Matthew Pfeffer as acting Chief Executive Officer.
-
Second Sight Medical Products Announces Closing of $27.9 Million Private Placement of Common Stock
3/26/2021
Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced that it has closed its previously announced private placement, which resulted in gross proceeds to Second Sight of $27.9 million, before deducting offering expenses.
-
Second Sight Medical Products Announces $27.9 Million Private Placement of Common Stock
3/24/2021
Second Sight Medical Products, Inc. (NASDAQ: EYES), (the "Company" or "Second Sight"), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced that it has entered into definitive securities purchase agreements with accredited investors for a private placement that will result in gross proceeds to Second Sight
-
Second Sight Medical Products Provides Business Update
4/28/2020
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announced that the Company has taken significant steps to reduce overhead and conserve liquidity as it continues operations while assessing strategic options.
-
Second Sight Announces $2.4 Million, Four-Year Grant from National Institutes of Health to Develop Spatial Localization and Mapping Technology
10/1/2019
Initiative a Joint Collaboration with the John Hopkins University Applied Physics Laboratory
-
Second Sight to Present at 20th Annual B. Riley FBR Investor Conference
5/16/2019
Second Sight Medical Products, Inc. announced that John T. Blake, Chief Financial Officer, will present at 20th Annual B. Riley FBR Investor Conference
-
Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System
5/15/2019
Second Sight Medical Products, Inc announced its plan to accelerate the development and commercialization of its Orion Visual Cortical Prosthesis System.
-
Second Sight Reports First Quarter 2019 Financial Results
5/15/2019
Company to Accelerate Development of Orion® Visual Cortical Prosthesis System
-
Second Sight to Discuss First Quarter 2019 Financial Results on May 15, 2019 Conference Call
5/8/2019
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, will release its financial results for the first quarter of 2019 on Wednesday, May 15, 2019, after the close of the U.S. financial markets.
-
Second Sight Medical Products, Inc. Presents Positive Interim Results at the Fifth Annual BRAIN Initiative® Investigators Meeting
4/11/2019
Presentation to Provide Update of Early Feasibility Study of the Orion® Visual Prosthesis System
-
Second Sight Medical Products, Inc. Announces Completion of Rights Offering
2/21/2019
Expiration date of all outstanding warrants listed for trading under the “EYESW” symbol is extended to 5:00 p.m. New York time on March 14, 2024
-
Second Sight Completes $4 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
10/22/2018
This placement of common stock is anticipated to yield gross proceeds of approximately $4 million to the Company.
-
Second Sight Reports Second Quarter 2018 Financial Results
8/7/2018
Achieves program milestones as Orion clinical and R&D activities advance
-
Second Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference Call
5/3/2018
Second Sight Medical Products, Inc. will release its 2018 first quarter financial results on Thursday, May 10, 2018
-
Second Sight Appoints John T. Blake Chief Financial Officer
3/22/2018
Mr. Blake succeeds Thomas Miller, who has served as Chief Financial Officer since 2014.
-
Second Sight Appoints Gregg Williams as Chairman of the Board of Directors
3/16/2018
Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that the Board of Directors has appointed Mr. Gregg Williams as Chairman of the Board, effective immediately